Aurobindo Pharma has informed that it enclosed a copy of the Postal Ballot Notice dated November 4, 2026 together with the Explanatory Statement thereto, seeking approval of the Members for: Reappointment of Mangalam Ramasubramanian Kumar (DIN: 03628755), as an Independent Director of the Company not liable to retire by rotation, for a second term of 5 (Five) consecutive years commencing from April 1, 2027 to March 31, 2032; Revision of remuneration of K. Nithyananda Reddy (DIN: 01284195), Vice Chairman & Managing Director of the Company; Revision of remuneration of Dr. M. Madan Mohan Reddy (DIN: 01284266), Whole-time Director of the Company; Revision in the commission payable to the independent directors of the Company.
The above information is a part of company’s filings submitted to BSE.